PURPOSE: Minimum rim width (MRW) and area (MRA) have been introduced as anatomically defensible measures of neuroretinal rim tissue observable using spectral-domain optical coherence tomography (SDOCT). They have been reported to change earlier than retinal nerve fiber layer thickness (RNFLT) in glaucoma. This study sought to determine which is better to distinguish subsequent change from variability, using the previously described longitudinal signal-to-noise ratio (LSNR). METHODS: Data from 157 eyes of 157 participants with high-risk ocular hypertension or non-end-stage glaucoma (mean deviation [MD] from -22 to +3 dB) were used. Participants were tested approximately every 6 months for at least six visits. For each eye, MRW, MRA, and RNFLT were regressed linearly against time. Longitudinal signal-to-noise ratio for each eye was defined as the rate of change over time (signal) divided by the standard deviation of residuals from this trend (noise). These were compared between parameters using a Wilcoxon signed rank test. RESULTS: The median LSNRs were -0.58y⁻¹ for RNFLT (bootstrapped 95% confidence interval -0.69 to -0.48y⁻¹); -0.44y⁻¹ (-0.59 to -0.32y⁻¹) for MRW; and -0.23y⁻¹ (-0.32 to -0.08y⁻¹) for MRA. Longitudinal signal-to-noise ratios were significantly more negative for RNFLT than for MRW (P = 0.025) or for MRA (P < 0.001). CONCLUSIONS: Retinal nerve fiber layer thickness measured by SDOCT had a better LSNR than MRW or MRA. Although MRW and MRA may be more sensitive for early detection of glaucomatous damage, these data suggest that RNFLT may be preferable for monitoring change.
PURPOSE: Minimum rim width (MRW) and area (MRA) have been introduced as anatomically defensible measures of neuroretinal rim tissue observable using spectral-domain optical coherence tomography (SDOCT). They have been reported to change earlier than retinal nerve fiber layer thickness (RNFLT) in glaucoma. This study sought to determine which is better to distinguish subsequent change from variability, using the previously described longitudinal signal-to-noise ratio (LSNR). METHODS: Data from 157 eyes of 157 participants with high-risk ocular hypertension or non-end-stage glaucoma (mean deviation [MD] from -22 to +3 dB) were used. Participants were tested approximately every 6 months for at least six visits. For each eye, MRW, MRA, and RNFLT were regressed linearly against time. Longitudinal signal-to-noise ratio for each eye was defined as the rate of change over time (signal) divided by the standard deviation of residuals from this trend (noise). These were compared between parameters using a Wilcoxon signed rank test. RESULTS: The median LSNRs were -0.58y⁻¹ for RNFLT (bootstrapped 95% confidence interval -0.69 to -0.48y⁻¹); -0.44y⁻¹ (-0.59 to -0.32y⁻¹) for MRW; and -0.23y⁻¹ (-0.32 to -0.08y⁻¹) for MRA. Longitudinal signal-to-noise ratios were significantly more negative for RNFLT than for MRW (P = 0.025) or for MRA (P < 0.001). CONCLUSIONS: Retinal nerve fiber layer thickness measured by SDOCT had a better LSNR than MRW or MRA. Although MRW and MRA may be more sensitive for early detection of glaucomatous damage, these data suggest that RNFLT may be preferable for monitoring change.
Authors: Michael D Roberts; Vicente Grau; Jonathan Grimm; Juan Reynaud; Anthony J Bellezza; Claude F Burgoyne; J Crawford Downs Journal: Invest Ophthalmol Vis Sci Date: 2008-09-20 Impact factor: 4.799
Authors: Stuart K Gardiner; Shaban Demirel; Carlos Gustavo De Moraes; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass Journal: Invest Ophthalmol Vis Sci Date: 2013-02-15 Impact factor: 4.799
Authors: Stuart K Gardiner; Ruojin Ren; Hongli Yang; Brad Fortune; Claude F Burgoyne; Shaban Demirel Journal: Am J Ophthalmol Date: 2013-11-13 Impact factor: 5.258
Authors: Brad Fortune; Hongli Yang; Nicholas G Strouthidis; Grant A Cull; Jonathan L Grimm; J Crawford Downs; Claude F Burgoyne Journal: Invest Ophthalmol Vis Sci Date: 2009-05-06 Impact factor: 4.799
Authors: Grant A Cull; Juan Reynaud; Lin Wang; George A Cioffi; Claude F Burgoyne; Brad Fortune Journal: Invest Ophthalmol Vis Sci Date: 2012-11-21 Impact factor: 4.799
Authors: Facundo G Sanchez; David S Sanders; Jessica J Moon; Stuart K Gardiner; Juan Reynaud; Brad Fortune; Steven L Mansberger Journal: Ophthalmol Glaucoma Date: 2019-10-04
Authors: Christopher Bowd; Linda M Zangwill; Robert N Weinreb; Christopher A Girkin; Massimo A Fazio; Jeffrey M Liebmann; Akram Belghith Journal: Am J Ophthalmol Date: 2018-09-07 Impact factor: 5.258
Authors: Steven L Mansberger; Shivali A Menda; Brad A Fortune; Stuart K Gardiner; Shaban Demirel Journal: Am J Ophthalmol Date: 2016-11-04 Impact factor: 5.258
Authors: Mohammad Saleh Miri; Michael D Abràmoff; Young H Kwon; Milan Sonka; Mona K Garvin Journal: Med Image Anal Date: 2017-05-06 Impact factor: 8.545